pentazocine has been researched along with Glaucoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beisel, A; Berman, L; Bollinger, K; De Greef, O; Mysona, BA; Patel, PA; Smith, SB; Zhao, J | 1 |
| Bollinger, KE; Mysona, BA; Smith, S; Zhao, J | 1 |
2 other study(ies) available for pentazocine and Glaucoma
| Article | Year |
|---|---|
Sigma-1 receptor agonist, (+)-pentazocine, is neuroprotective in a Brown Norway rat microbead model of glaucoma.
Topics: Animals; Disease Models, Animal; Female; Glaucoma; Injections, Intraocular; Intraocular Pressure; Male; Microspheres; Neuroprotection; Pentazocine; Rats; Rats, Inbred BN; Retinal Ganglion Cells; Sigma-1 Receptor | 2023 |
Relationship between Sigma-1 receptor and BDNF in the visual system.
Topics: Analgesics, Opioid; Animals; Astrocytes; Blotting, Western; Brain-Derived Neurotrophic Factor; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Glaucoma; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Optic Disk; Pentazocine; Rats; Rats, Sprague-Dawley; Receptors, sigma; Retina; Sigma-1 Receptor | 2018 |